Synthetic Molecule Design and Development (SMDD) is an innovation-focused organization within Eli Lilly and Company. SMDD is involved in key activities for the development of synthetic active pharmaceutical ingredients and drug products from pre-clinical phases through commercialization. Our dynamic group is made up of chemists, pharmaceutical scientists, analytical chemists, and engineers. We strive to identify, develop and apply groundbreaking technologies to deliver maximum benefit to our patients. SMDD delivers on these responsibilities by recognizing diverse talent and cultures are necessary to bring the next generation of life changing medicines to patients.
Our team is looking for an ambitious post-doctoral scientist with strong research and communication skills to contribute to highly visible research projects. You will reside in the Particle Design Laboratory (PDL) within SMDD, which serves as a core competency center for particle and crystallization process design. Your work will improve our strategies for solid-form isolation of small molecule APIs through both basic and applied research. In this role, you will:
Minimum Qualifications:
About Eli Lilly’s Postdoctoral Scientist Program:
When it comes to research and development, our goal is to discover and deliver innovative medicines that make life better for people around the world. It’s challenging, expensive and often filled with failure. But even when we fail, we advance medical science and understanding by learning more about diseases, biology and chemistry – ultimately bringing new solutions one step closer to reality.
Over the course of our history, we have shed light on some of the toughest health care problems known to man – diabetes, heart disease, infectious diseases, neuroscience disorders, cancer and more. We could not pursue this without our research and development team.
Postdoctoral scientists help us continue this pursuit. During your experience you will get:
Funding Announcement: Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP)
CMAC are excited to announce the new £1.2M award from EPSRC to lead the new international collaboration for Digital Design and Manufacture of Amorphous Pharmaceuticals (DDMAP).
This award brings together three world-leading research groups from the UK (CMAC, University of Strathclyde), Denmark (CPHarma, University of Copenhagen) and Belgium (CESPE, Ghent University) to deliver a step change in fundamental understanding of amorphous materials that will apply to real industrial challenges in medicines manufacturing. This unique centre will create a dynamic collaboration across Europe that will embrace open science and offer multi-disciplinary and multi-organisational research engagement. .... more
CMAC Vacancies
CMAC is #hiring! 📢
Do you want to make a difference in the world of #medicinesmanufacturing research? We have some amazing opportunities to join #CMAC, a world leading research centre at the heart of cutting edge innovation.
💊 We are always looking for diverse and inspiring talent
💊 We offer flexible and agile working across our opportunities
💊 We have roles for various skills and career stages
With over 10 vacancies available and more in the pipeline, there has never been a better time to contribute to our broad portfolio of #research, #translation and #skills in award-winning #facilities in #collaboration with global #pharma and technology providers.
.... more